"Designing Growth Strategies is in our DNA"

Prostate Cancer Radiation Therapeutics Market Size, Share & Industry Analysis, By Radioisotopes (Radium-223, Lutetium-177, and Others) By Type (Metastatic Castration-Resistant Prostate Cancer and Non-Metastatic Castration-Resistant Prostate Cancer), By End-User (Hospitals, Specialty Clinics, and Others), and Regional Forecast, 2025-2032

Last Updated: November 24, 2025 | Format: PDF | Report ID: FBI112713

 

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Prevalence of Prostate Cancer - by Key Countries/Regions, 2024
    2. Pipeline Analysis, by Key Players
    3. Overview of Alternative Therapies
    4. New Product Launches, by Key Players
    5. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)
    6. Impact of COVID-19 on the Market
  5. Global Prostate Cancer Radiation Therapeutics Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Radioisotope
      1. Radium-223
      2. Lutetium-177
      3. Others  
    2. Market Analysis, Insights and Forecast – By Type
      1. Metastatic Castration-Resistant Prostate Cancer
      2. Non-Metastatic Castration-Resistant Prostate Cancer
    3. Market Analysis, Insights and Forecast – By End-user
      1. Hospitals
      2. Specialty Clinics
      3. Others
    4. Market Analysis, Insights and Forecast – Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Rest of the World
  6. North America Prostate Cancer Radiation Therapeutics Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Radioisotope
      1. Radium-223
      2. Lutetium-177
      3. Others  
    2. Market Analysis, Insights and Forecast – By Type
      1. Metastatic Castration-Resistant Prostate Cancer
      2. Non-Metastatic Castration-Resistant Prostate Cancer
    3. Market Analysis, Insights and Forecast – By End-user
      1. Hospitals
      2. Specialty Clinics
      3. Others
    4. Market Analysis, Insights and Forecast – By Country
      1. U.S.
      2. Canada
  7. Europe Prostate Cancer Radiation Therapeutics Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Radioisotope
      1. Radium-223
      2. Lutetium-177
      3. Others  
    2. Market Analysis, Insights and Forecast – By Type
      1. Metastatic Castration-Resistant Prostate Cancer
      2. Non-Metastatic Castration-Resistant Prostate Cancer
    3. Market Analysis, Insights and Forecast – By End-user
      1. Hospitals
      2. Specialty Clinics
      3. Others
    4. Market Analysis, Insights and Forecast – By Country/ Sub-Region
      1. Germany
      2. U.K.
      3. France
      4. Italy
      5. Spain
      6. Scandinavia
      7. Rest of Europe
  8. Asia Pacific Prostate Cancer Radiation Therapeutics Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Radioisotope
      1. Radium-223
      2. Lutetium-177
      3. Others  
    2. Market Analysis, Insights and Forecast – By Type
      1. Metastatic Castration-Resistant Prostate Cancer
      2. Non-Metastatic Castration-Resistant Prostate Cancer
    3. Market Analysis, Insights and Forecast – By End-user
      1. Hospitals
      2. Specialty Clinics
      3. Others
    4. Market Analysis, Insights and Forecast – By Country/ Sub-Region
      1. China
      2. Japan
      3. India
      4. Australia
      5. Southeast Asia
      6. Rest of Asia Pacific
  9. Rest of the World Prostate Cancer Radiation Therapeutics Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Radioisotope
      1. Radium-223
      2. Lutetium-177
      3. Others  
    2. Market Analysis, Insights and Forecast – By Type
      1. Metastatic Castration-Resistant Prostate Cancer
      2. Non-Metastatic Castration-Resistant Prostate Cancer
    3. Market Analysis, Insights and Forecast – By End-user
      1. Hospitals
      2. Specialty Clinics
      3. Others
  10. Competitive Analysis
    1. Global Market Share Analysis (2024)
    2. Company Profiles (Overview, Products, SWOT analysis, Recent developments, strategies, financials (based on availability)
      1. Novartis AG
      2. Bayer AG
      3. Telix Pharmaceuticals Limited
      4. Ariceum Therapeutics
      5. Radiopharm Theranostics Limited
      6. Lantheus Holdings, Inc.
      7. Clarity Pharmaceuticals  
  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Prevalence of Prostate Cancer - by Key Countries/Regions, 2024
    2. Pipeline Analysis, by Key Players
    3. Overview of Alternative Therapies
    4. New Product Launches, by Key Players
    5. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)
    6. Impact of COVID-19 on the Market
  5. Global Prostate Cancer Radiation Therapeutics Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Radioisotope
      1. Radium-223
      2. Lutetium-177
      3. Others  
    2. Market Analysis, Insights and Forecast – By Type
      1. Metastatic Castration-Resistant Prostate Cancer
      2. Non-Metastatic Castration-Resistant Prostate Cancer
    3. Market Analysis, Insights and Forecast – By End-user
      1. Hospitals
      2. Specialty Clinics
      3. Others
    4. Market Analysis, Insights and Forecast – Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Rest of the World
  6. North America Prostate Cancer Radiation Therapeutics Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Radioisotope
      1. Radium-223
      2. Lutetium-177
      3. Others  
    2. Market Analysis, Insights and Forecast – By Type
      1. Metastatic Castration-Resistant Prostate Cancer
      2. Non-Metastatic Castration-Resistant Prostate Cancer
    3. Market Analysis, Insights and Forecast – By End-user
      1. Hospitals
      2. Specialty Clinics
      3. Others
    4. Market Analysis, Insights and Forecast – By Country
      1. U.S.
      2. Canada
  7. Europe Prostate Cancer Radiation Therapeutics Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Radioisotope
      1. Radium-223
      2. Lutetium-177
      3. Others  
    2. Market Analysis, Insights and Forecast – By Type
      1. Metastatic Castration-Resistant Prostate Cancer
      2. Non-Metastatic Castration-Resistant Prostate Cancer
    3. Market Analysis, Insights and Forecast – By End-user
      1. Hospitals
      2. Specialty Clinics
      3. Others
    4. Market Analysis, Insights and Forecast – By Country/ Sub-Region
      1. Germany
      2. U.K.
      3. France
      4. Italy
      5. Spain
      6. Scandinavia
      7. Rest of Europe
  8. Asia Pacific Prostate Cancer Radiation Therapeutics Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Radioisotope
      1. Radium-223
      2. Lutetium-177
      3. Others  
    2. Market Analysis, Insights and Forecast – By Type
      1. Metastatic Castration-Resistant Prostate Cancer
      2. Non-Metastatic Castration-Resistant Prostate Cancer
    3. Market Analysis, Insights and Forecast – By End-user
      1. Hospitals
      2. Specialty Clinics
      3. Others
    4. Market Analysis, Insights and Forecast – By Country/ Sub-Region
      1. China
      2. Japan
      3. India
      4. Australia
      5. Southeast Asia
      6. Rest of Asia Pacific
  9. Rest of the World Prostate Cancer Radiation Therapeutics Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Radioisotope
      1. Radium-223
      2. Lutetium-177
      3. Others  
    2. Market Analysis, Insights and Forecast – By Type
      1. Metastatic Castration-Resistant Prostate Cancer
      2. Non-Metastatic Castration-Resistant Prostate Cancer
    3. Market Analysis, Insights and Forecast – By End-user
      1. Hospitals
      2. Specialty Clinics
      3. Others
  10. Competitive Analysis
    1. Global Market Share Analysis (2024)
    2. Company Profiles (Overview, Products, SWOT analysis, Recent developments, strategies, financials (based on availability)
      1. Novartis AG
      2. Bayer AG
      3. Telix Pharmaceuticals Limited
      4. Ariceum Therapeutics
      5. Radiopharm Theranostics Limited
      6. Lantheus Holdings, Inc.
      7. Clarity Pharmaceuticals  
Read Less

Figure 1:  Global Prostate Cancer Radiation Therapeutics Market Revenue Breakdown (USD billion, %) by Region, 2024 & 2032

Figure 2:  Global Prostate Cancer Radiation Therapeutics Market Value Share (%), by Radioisotope, 2024 & 2032

Figure 3:  Global Prostate Cancer Radiation Therapeutics Market Value Share (%), by Type, 2024 & 2032

Figure 4:  Global Prostate Cancer Radiation Therapeutics Market Value Share (%), by End-User, 2024 & 2032

Figure 5:  North America Prostate Cancer Radiation Therapeutics Market Value (USD billion), by Radioisotope, 2024 & 2032

Figure 6:  North America Prostate Cancer Radiation Therapeutics Market Value Share (%), by Radioisotope, 2024

Figure 7:  North America Prostate Cancer Radiation Therapeutics Market Value (USD billion), by Type, 2024 & 2032

Figure 8:  North America Prostate Cancer Radiation Therapeutics Market Value Share (%), by Type, 2024

Figure 9:  North America Prostate Cancer Radiation Therapeutics Market Value (USD billion), by End-User, 2024 & 2032

Figure 10:  North America Prostate Cancer Radiation Therapeutics Market Value Share (%), by End-User, 2024

Figure 11:  North America Prostate Cancer Radiation Therapeutics Market Value (USD billion), By Country, 2024 & 2032

Figure 12:  North America Prostate Cancer Radiation Therapeutics Market Value Share (%), By Country, 2024

Figure 13:  Europe Prostate Cancer Radiation Therapeutics Market Value (USD billion), by Radioisotope, 2024 & 2032

Figure 14:  Europe Prostate Cancer Radiation Therapeutics Market Value Share (%), by Radioisotope, 2024

Figure 15:  Europe Prostate Cancer Radiation Therapeutics Market Value (USD billion), by Type, 2024 & 2032

Figure 16:  Europe Prostate Cancer Radiation Therapeutics Market Value Share (%), by Type, 2024

Figure 17:  Europe Prostate Cancer Radiation Therapeutics Market Value (USD billion), by End-User, 2024 & 2032

Figure 18:  Europe Prostate Cancer Radiation Therapeutics Market Value Share (%), by End-User, 2024

Figure 19:  Europe Prostate Cancer Radiation Therapeutics Market Value (USD billion), By Country/ Sub-region, 2024 & 2032

Figure 20:  Europe Prostate Cancer Radiation Therapeutics Market Value Share (%), By Country/ Sub-region, 2024

Figure 21:  Asia Pacific Prostate Cancer Radiation Therapeutics Market Value (USD billion), by Radioisotope, 2024 & 2032

Figure 22:  Asia Pacific Prostate Cancer Radiation Therapeutics Market Value Share (%), by Radioisotope, 2024

Figure 23:  Asia Pacific Prostate Cancer Radiation Therapeutics Market Value (USD billion), by Type, 2024 & 2032

Figure 24:  Asia Pacific Prostate Cancer Radiation Therapeutics Market Value Share (%), by Type, 2024

Figure 25:  Asia Pacific Prostate Cancer Radiation Therapeutics Market Value (USD billion), by End-User, 2024 & 2032

Figure 26:  Asia Pacific Prostate Cancer Radiation Therapeutics Market Value Share (%), by End-User, 2024

Figure 27:  Asia Pacific Prostate Cancer Radiation Therapeutics Market Value (USD billion), By Country/ Sub-region, 2024 & 2032

Figure 28:  Asia Pacific Prostate Cancer Radiation Therapeutics Market Value Share (%), By Country/ Sub-region, 2024

Figure 29:  Rest of the World Prostate Cancer Radiation Therapeutics Market Value (USD billion), by Radioisotope, 2024 & 2032

Figure 30:  Rest of the World Prostate Cancer Radiation Therapeutics Market Value Share (%), by Radioisotope, 2024

Figure 31:  Rest of the World Prostate Cancer Radiation Therapeutics Market Value (USD billion), by Type, 2024 & 2032

Figure 32:  Rest of the World Prostate Cancer Radiation Therapeutics Market Value Share (%), by Type, 2024

Figure 33:  Rest of the World Prostate Cancer Radiation Therapeutics Market Value (USD billion), by End-User, 2024 & 2032

Figure 34:  Rest of the World Prostate Cancer Radiation Therapeutics Market Value Share (%), by End-User, 2024

Figure 35:  Global Prostate Cancer Radiation Therapeutics Market Share (%), By Company, 2024

Table 1:  Global Prostate Cancer Radiation Therapeutics Market Revenue (USD billion) Forecast, by Radioisotope, 2019–2032

Table 2:  Global Prostate Cancer Radiation Therapeutics Market Revenue (USD billion) Forecast, by Type, 2019–2032

Table 3:  Global Prostate Cancer Radiation Therapeutics Market Revenue (USD billion) Forecast, by End-User, 2019–2032

Table 4:  Global Prostate Cancer Radiation Therapeutics Market Revenue (USD billion) Forecast, by Region, 2019-2032

Table 5:  North America Prostate Cancer Radiation Therapeutics Market Revenue (USD billion) Forecast, by Radioisotope, 2019–2032

Table 6:  North America Prostate Cancer Radiation Therapeutics Market Revenue (USD billion) Forecast, by Type, 2019–2032

Table 7:  North America Prostate Cancer Radiation Therapeutics Market Revenue (USD billion) Forecast, by End-User, 2019–2032

Table 8:  North America Prostate Cancer Radiation Therapeutics Market Revenue (USD billion) Forecast, By Country, 2019-2032

Table 9:  Europe Prostate Cancer Radiation Therapeutics Market Revenue (USD billion) Forecast, by Radioisotope, 2019–2032

Table 10:  Europe Prostate Cancer Radiation Therapeutics Market Revenue (USD billion) Forecast, by Type, 2019–2032

Table 11:  Europe Prostate Cancer Radiation Therapeutics Market Revenue (USD billion) Forecast, by End-User, 2019–2032

Table 12:  Europe Prostate Cancer Radiation Therapeutics Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

Table 13:  Asia Pacific Prostate Cancer Radiation Therapeutics Market Revenue (USD billion) Forecast, by Radioisotope, 2019–2032

Table 14:  Asia Pacific Prostate Cancer Radiation Therapeutics Market Revenue (USD billion) Forecast, by Type, 2019–2032

Table 15:  Asia Pacific Prostate Cancer Radiation Therapeutics Market Revenue (USD billion) Forecast, by End-User, 2019–2032

Table 16:  Asia Pacific Prostate Cancer Radiation Therapeutics Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

Table 17:  Rest of the World Prostate Cancer Radiation Therapeutics Market Revenue (USD billion) Forecast, by Radioisotope, 2019–2032

Table 18:  Rest of the World Prostate Cancer Radiation Therapeutics Market Revenue (USD billion) Forecast, by Type, 2019–2032

Table 19:  Rest of the World Prostate Cancer Radiation Therapeutics Market Revenue (USD billion) Forecast, by End-User, 2019–2032

Prostate Cancer Radiation Therapeutics Market
  • 2019-2032
  • 2024
  • 2019-2023
  • 189
Download Free Sample

    man icon
    Mail icon
    Captcha refresh
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann

Related Reports